Trk ligand program (PharmatrophiX)

N/A

Report date: 2025/01/26 15:39:51

NME

Base Information

Drug NameTrk ligand program (PharmatrophiX)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 modulatorsNeurotrophic tyrosine kinase receptor type 3 modulators

TargetsNeurotrophic tyrosine kinase receptor type 3Neurotrophic tyrosine kinase receptor type 2

Therapy Area/IndicationsNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIreland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharmatrophix Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNervous System Diseases

Inactive IndicationsN/A

ATC CodeN/A